News

31 May 2018 On May 31, 2018 the European Business Angels Network (EBAN) and the European Agency for Small and ...
Read More

19 May, 2018 Sensius is sponsor of the European Society for Hyperthermic Oncology (ESHO). During the annual conference in May ...
Read More

1 May, 2018 In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on ...
Read More

19 April 2018 Sensius won the Venture Cup Award of Startup Olé SalamancaCompanies with the European Seal of Excellence from ...
Read More

February 2018 In December 2017 our CEO Paul van den Biggelaar was interviewed by the Life Sciences & Health 010 ...
Read More

Februari 2018 In February 2018 Sensius was invited for a pitch among other Dutch innovative startups during the congress Innovation ...
Read More

Rotterdam, 24 December 2017 MedValue: “High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer” The ...
Read More

Gerard van Rhoon was honored by receiving the 28th J. Eugene Robinson1 award, which is the most prestigious price of ...
Read More

At ESHO2017 in Athens, Sarah Brueningk received the Sensius Young Investigator Award for her presentation "Simulating response to multimodality therapies ...
Read More

Sensius, an Erasmus MC Spinoff company developing novel cancer treatment using hyperthermia, is receiving €300,000 from the UNIIQ investment fund ...
Read More